FeesSafety
Pluang+

Halper Sadeh LLC investigates if Surgery Partners' $23.50/share sale offer is fair to shareholders.

Market News
20 Nov 2026, 02:38 WIB
GlobeNewsWire
View Source
Bearish
Halper Sadeh LLC investigates if Surgery Partners' $23.50/share sale offer is fair to shareholders.

Halper Sadeh LLC is investigating the proposed sale of Surgery Partners, Inc. to HealthSpan Partners for $23.50 per share in cash. The investigation questions whether Surgery Partners' board fulfilled their duties by securing the best price, conducting a fair sales process, and fully disclosing material information to shareholders. The law firm may seek higher compensation or additional disclosures on behalf of shareholders. This inquiry highlights potential conflicts of interest and aims to protect shareholder rights in the transaction.

The investigation by Halper Sadeh LLC into Surgery Partners, Inc.'s sale price comes as a backdrop to a declining health sector on Pluang, where 130 of 150 US health-sector stocks fell. For readers following health stocks, here is Pluang's market snapshot as of Nov 20, 2026 07:01 WIB: Oscar Health Inc (OSCR) dropped 6.02% to USD 25.91 with a typical hold time of 17 days, Tango Therapeutics Inc. (TNGX) rose 5.89% to USD 23.18 with a typical hold time of 5 days, and Zoetis Inc (ZTS) fell 5.89% to USD 80.51, with Pluang order activity showing 100% sell and a typical hold time of 69 days.

More News

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

The S&P 500 recently experienced a four-week losing streak following a record high, dropping about 8% from its peak. Historically, such declines have often been healthy pullbacks rather than signs of a bear market, with the index showing gains six an...

Market News
Bullish
1 hour ago
Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute (UTI) reported a 6% increase in fourth-quarter revenue to $235.9 million, driven by a rise in full-time students. However, net income fell nearly 4% to just over $18 million, missing analyst earnings per share estimates....

Company Fundamentals
Bearish
1 hour ago
Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Investor Michael Burry highlighted risks in CoreWeave, Nebius, Nvidia, and semiconductor stocks, noting significant price drops due to rising borrowing costs and potential long-term challenges for Nvidia's competitive edge. CoreWeave and Nebius have ...

Market News
Bearish
1 hour ago
AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD is gaining ground on Nvidia in the AI chip market, with its data center revenue nearly doubling year over year in Q3 and overall revenue up 45%. Nvidia faces leadership uncertainty after former CEO Jensen Huang's departure, creating an opportunit...

Market News
Bullish
1 hour ago
Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's investigational drug JNJ-6143, acquired through a $3.05 billion purchase of Halda Therapeutics, demonstrated a 75% overall response rate in a Phase 1 trial for metastatic castration-resistant prostate cancer. This promising early ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App